OncoCyte (OCX)
(Delayed Data from NSDQ)
$3.12 USD
+0.01 (0.32%)
Updated Aug 26, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.36 |
Last EPS Surprise | NA |
ABR | 2.40 |
Earnings ESP
|
NA |
---|---|
Current Year | -2.58 |
Next Year | NA |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.43M | NA | 1.50M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -2.58 | NA |
# of Estimates | NA | NA | 1 | NA |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | -2.58 | NA |
Low Estimate | NA | NA | -2.58 | NA |
Year ago EPS | -0.57 | NA | -4.37 | -2.58 |
Year over Year Growth Est. | NA | NA | 40.96% | NA |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | NA |
Up Last 30 Days | NA | NA | 0 | NA |
Up Last 60 Days | NA | NA | 0 | NA |
Down Last 7 Days | NA | NA | 0 | NA |
Down Last 30 Days | NA | NA | 0 | NA |
Down Last 60 Days | NA | NA | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -2.58 | NA |
7 Days Ago | NA | NA | -2.58 | NA |
30 Days Ago | NA | NA | -2.58 | NA |
60 Days Ago | NA | NA | -2.58 | NA |
90 Days Ago | NA | NA | -2.61 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -2.58 | NA |
Zacks Consensus Estimate | NA | NA | -2.58 | NA |
Earnings ESP | NA | NA | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -1.13 | NA | -0.57 | NA |
Estimate | NA | NA | NA | -1.52 | NA |
Difference | NA | NA | NA | 0.95 | 0.95 |
Surprise | NA | NA | NA | 62.50% | 62.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more